BACKGROUND: Somatic depressive symptoms and certain biomarkers are each associated with worse acute myocardial infarction (AMI) prognosis, but the relationship between depressive symptom domains and inflammatory, neurohormonal, and coagulation markers is unknown. METHODS: We examined the relationship between depressive symptoms and 1-month biomarker levels (high-sensitivity C-reactive protein [hs-CRP], N-terminal pro-brain natriuretic peptide [NT-proBNP], white blood cell [WBC], platelet counts) in 1265 AMI patients. Depressive symptoms (9-item Patient Health Questionnaire) were assessed during index hospitalization and categorized as somatic or cognitive. Using median regression models, the upper quartile of somatic and cognitive depression scores and each biomarker were compared with the lower three quartiles, adjusting for site, demographics, and clinical characteristics. RESULTS: Although hs-CRP values were higher in patients with somatic symptoms, this association was attenuated after adjustment (B(per SD increase) = .02, 95% confidence interval: .00; .05, p = .07). WBC count was independently associated with somatic depressive symptoms (B(per SD increase) = .28, 95% confidence interval: .12; .44, p < .001). Cognitive depressive symptoms were not associated with hs-CRP or WBC count. Neither dimension was associated with NT-proBNP or platelet levels. For each biomarker, the depression dimensions explained <1% of their variation. CONCLUSIONS: Neither somatic nor cognitive depressive symptoms were meaningfully associated with hs-CRP, NT-proBNP, WBC, or platelet counts 1 month after AMI, suggesting that the association between depression and long-term outcomes may be unrelated to these biomarkers. Future research should explore other biomarkers to better illuminate pathways by which depression adversely impacts AMI prognosis.
BACKGROUND:Somatic depressive symptoms and certain biomarkers are each associated with worse acute myocardial infarction (AMI) prognosis, but the relationship between depressive symptom domains and inflammatory, neurohormonal, and coagulation markers is unknown. METHODS: We examined the relationship between depressive symptoms and 1-month biomarker levels (high-sensitivity C-reactive protein [hs-CRP], N-terminal pro-brain natriuretic peptide [NT-proBNP], white blood cell [WBC], platelet counts) in 1265 AMI patients. Depressive symptoms (9-item Patient Health Questionnaire) were assessed during index hospitalization and categorized as somatic or cognitive. Using median regression models, the upper quartile of somatic and cognitive depression scores and each biomarker were compared with the lower three quartiles, adjusting for site, demographics, and clinical characteristics. RESULTS: Although hs-CRP values were higher in patients with somatic symptoms, this association was attenuated after adjustment (B(per SD increase) = .02, 95% confidence interval: .00; .05, p = .07). WBC count was independently associated with somatic depressive symptoms (B(per SD increase) = .28, 95% confidence interval: .12; .44, p < .001). Cognitive depressive symptoms were not associated with hs-CRP or WBC count. Neither dimension was associated with NT-proBNP or platelet levels. For each biomarker, the depression dimensions explained <1% of their variation. CONCLUSIONS: Neither somatic nor cognitive depressive symptoms were meaningfully associated with hs-CRP, NT-proBNP, WBC, or platelet counts 1 month after AMI, suggesting that the association between depression and long-term outcomes may be unrelated to these biomarkers. Future research should explore other biomarkers to better illuminate pathways by which depression adversely impacts AMI prognosis.
Authors: Torbjørn Omland; James A de Lemos; David A Morrow; Elliot M Antman; Christopher P Cannon; Christian Hall; Eugene Braunwald Journal: Am J Cardiol Date: 2002-02-15 Impact factor: 2.778
Authors: Peter de Jonge; Johan Ormel; Rob H S van den Brink; Joost P van Melle; Titia A Spijkerman; Astrid Kuijper; Dirk J van Veldhuisen; Maarten P van den Berg; Adriaan Honig; Harry J G M Crijns; Aart H Schene Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: Anish S Shah; Alvaro Alonso; Eric A Whitsel; Elsayed Z Soliman; Viola Vaccarino; Amit J Shah Journal: J Am Heart Assoc Date: 2021-02-26 Impact factor: 5.501
Authors: Allison J Carroll; Reto Auer; Laura A Colangelo; Mercedes R Carnethon; David R Jacobs; Jesse C Stewart; Rachel Widome; John Jeffrey Carr; Kiang Liu; Brian Hitsman Journal: J Dual Diagn Date: 2017-01-27
Authors: Benedetta Izzi; Alfonsina Tirozzi; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Marc F Hoylaerts; Licia Iacoviello; Alessandro Gialluisi Journal: Int J Mol Sci Date: 2020-11-21 Impact factor: 5.923
Authors: Matthias Michal; Jörg Wiltink; Yvonne Kirschner; Philipp S Wild; Thomas Münzel; Francisco M Ojeda; Tanja Zeller; Renate B Schnabel; Karl Lackner; Maria Blettner; Isabella Zwiener; Manfred E Beutel Journal: PLoS One Date: 2013-08-13 Impact factor: 3.240